Shaad E. Abdullah

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Paul Nathan, Jessica C. Hassel, Piotr Rutkowski et al. · New England Journal of Medicine · 2021 · 878 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

Qu Zhang, Jia Luo, Song Wu et al. · Cancer Discovery · 2020 · 336 citations · Full text

Medicine, Immunology, Oncology +17

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial

Richard D. Carvajal, Marcus O. Butler, Alexander N. Shoushtari et al. · Nature Medicine · 2022 · 152 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC

Scott Antonia, Ani Sarkis Balmanoukian, Julie R. Brahmer et al. · Journal of Thoracic Oncology · 2019 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

Neil H. Segal, Sai‐Hong Ignatius Ou, Ani Sarkis Balmanoukian et al. · European Journal of Cancer · 2019 · 86 citations

Medicine, Oncology, Oncology Pharmacotherapy +6